The effects of human herpesvirus 8 infection and interferon-γ response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals

British Journal of Dermatology

Volumn 159, Issue 4, 2008, Pages 839-846

  Guedes, F ^a   De Andrade Jr , H F ^a   Fernandes, E R ^a   Tuon, F F ^a   Brasil, R A ^a   Pagliari, C ^a   Duarte, M I S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Highly active antiretroviral therapy; Human herpesvirus 8; Immune response; Immunohistochemistry; Kaposi sarcoma

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; LATENCY ASSOCIATED NUCLEAR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 51849161903     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08755.x     Document Type: Article

References (35)

1. Ensoli B, Sgadari C, Barillari G et al. Biology of Kaposi's sarcoma. Eur J Cancer 2001 37 : 1251 69.
2. Yao L, Salvucci O, Cardones AR et al. Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood 2003 102 : 3900 5.
3. Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990 22 : 1237 50.
4. Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2002 2 : 281 92.
5. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994 266 : 1865 9.
6. Boshoff C, Weiss R. AIDS-related malignancies. Nat Rev Cancer 2002 2 : 373 82.
7. Gessain A, Duprez R. Spindle cells and their role in Kaposi's sarcoma. Int J Biochem Cell Biol 2005 37 : 2457 65.
8. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000 342 : 1027 38.
9. Katano H, Sato Y, Kurata T et al. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 2000 269 : 335 44.
10. Katano H, Sato Y, Kurata T et al. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 1999 155 : 47 52.
11. Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002 2 : 344 52.
12. Rappocciolo G, Jenkins FJ, Hensler HR et al. DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 2006 176 : 1741 9.
13. Fiorelli V, Gendelman R, Sirianni MC et al. Gamma-interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood 1998 91 : 956 67.
14. Pugliese A, Torre D, Saini A et al. Cytokine detection in HIV-1/HHV-8 co-infected subjects. Cell Biochem Funct 2002 20 : 191 4.
15. Torre D, Speranza F, Martegani R. Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection. HIV Med 2005 6 : 66 78.
16. Martinez V, Caumes E, Gambotti L et al. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. Br J Cancer 2006 94 : 1000 6.
17. Sgadari C, Monini P, Barillari G, Ensoli B. Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. Lancet Oncol 2003 4 : 537 47.
18. Bihl F, Mosam A, Henry LN et al. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS 2007 21 : 1245 52.
19. Aoki Y, Tosato G. Interactions between HIV-1 Tat and KSHV. Curr Top Microbiol Immunol 2007 312 : 309 26.
20. Monini P, Sgadari C, Toschi E et al. Antitumour effects of antiretroviral therapy. Nat Rev Cancer 2004 4 : 861 75.
21. Erber WN, Willis JI, Hoffman GJ. An enhanced immunocytochemical method for staining bone marrow trephine sections. J Clin Pathol 1997 50 : 389 93.
22. Tuon FF, Tonacio AC, Gryschek RC. Concomitant pleural and disseminated tuberculosis in Aids: immune response or HIV infection compartmentalization? Acta Trop 2007 104 : 79 83.
23. Pellet C, Chevret S, Blum L et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol 2001 117 : 858 63.
24. Pellet C, Chevret S, Frances C et al. Prognostic value of quantitative Kaposi sarcoma-associated herpesvirus load in posttransplantation Kaposi sarcoma. J Infect Dis 2002 186 : 110 13.
25. Pellet C, Delphine K, Dupuy A et al. Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma. J Invest Dermatol 2006 126 : 621 7.
26. Guihot A, Dupin N, Marcelin AG et al. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma. J Infect Dis 2006 194 : 1078 88.
27. Lambert M, Gannage M, Karras A et al. Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 2006 108 : 3871 80.
28. Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS 2003 17 : 1717 30.
29. Tuon FF, Mullata GC, Pinto PW et al. Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in AIDS patients. AIDS Patient Care STDS 2007 21 : 527 32.
30. Pozharskaya VP, Weakland LL, Offermann MK. Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells. J Gen Virol 2004 85 : 2779 87.
31. Krigel RL, Odajnyk CM, Laubenstein LJ et al. Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma. J Biol Response Mod 1985 4 : 358 64.
32. Nasti G, Martellotta F, Berretta M et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003 98 : 2440 6.
33. Pak F, Mwakigonja AR, Kokhaei P et al. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions. Eur J Cancer 2007 43 : 1877 82.
34. Kaaya E, Castanos-Velez E, Heiden T et al. Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma. Med Oncol 2000 17 : 325 32.
35. Asahi-Ozaki Y, Sato Y, Kanno T et al. Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases. J Infect Dis 2006 193 : 773 82.